Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis
Completed
- Conditions
- Atopic Dermatitis
- Registration Number
- NCT00098150
- Lead Sponsor
- Novartis
- Brief Summary
This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
- Consenting patients who participated in the core clinical trial
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method